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Thioredoxin-interacting protein (Txnip) knockout (TKO) mice exhibit impaired response to fasting.
Herein, we showed that activation of adenine monophosphate-activated protein kinase and cellular
AMP levels were diminished in the heart and soleus muscle but not in gastrocnemius muscle of fast-
ing TKOmice. Similarly, glycogen content in fasted TKOmice was increased in oxidative muscles but
was not different in glycolytic muscles. These data suggest Txnip deﬁciency has a higher impact on
oxidative muscle than glycolytic muscles and provide new insights into the metabolic role of Txnip.
 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction the metabolic perturbations by Txnip ablation are mainly due toThe ability to make proper adaptive biochemical and physiolog-
ical changes in response tonutritional status is vital to the survival of
all living organisms. Hence, the balance of metabolic fuel utilization
is tightly regulated and coordinated. Disruption of this intricate bal-
ance is manifested in many common diseases in Western societies,
such as obesity and diabetes. Previously, we and others showed that
thioredoxin-interacting protein (Txnip) knockout (TKO) mice were
unable to respond properly to energy deprivation [1–5]. Prolonged
starvation resulted in the death of 90% TKO mice within 72 h while
acute fasting led to profound alternations in the plasma metabolic
proﬁle of TKO mice which become hypoglycemic, hyperketonemic
and hypertriglyceridemic. Surprisingly, although the liver plays a
central role in fuel adaptation, liver-speciﬁc TKO mice do not have
any overt metabolic abnormalities [4]. On the other hand, cardiac
and skeletal muscle-speciﬁc TKO mice recapitulate the fasting
plasma metabolic proﬁle of whole body TKO mice, indicating thatchemical Societies. Published by E
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gy, David Geffen School of
Fax: +1 310 794 7345.its loss of function in the heart and skeletal muscle [4]. Mitochon-
drial oxidation of glucose, fatty acids and ketone bodies in skeletal
muscles was found to be reduced in TKO mice, whereas glucose
uptake and glycolysis were increased [4].
Txnip isa46 kDaubiquitouslyexpressedproteinwhich is involved
in maintaining cellular redox rheostat through its disulﬁde interac-
tion with thioredoxin-1 [6,7]. It is an important metabolic regulator
in controlling glucose homeostasis [1,4,5,8,9]. Elevated glucose levels
induce Txnip expression [10–12]. Conversely, Txnip expression sup-
presses glucose uptake and utilization [8,13]. Txnip mutations are
linked to lower plasma glucose in type 2 diabetic patients who have
elevated levels of Txnip in the pancreatic b-cells [8,13].
Adeninemonophosphate-activated protein kinase (AMPK) is the
master energy senor in the cell and orchestrates fasting-speciﬁc
metabolic responses (review in [14]). Activation of AMPK by
increased cellular AMP levels inhibits anabolic pathways and
promotes catabolic processes to restore ATP levels. Given the central
role of AMPK in energy sensing and maintaining energy homeosta-
sis, we investigated the possible link of Txnip ablation in skeletal
and cardiac muscles to AMPK signaling and glucose homeostasis.
2. Materials and methods
2.1. Animal studies
Generation of TKO mice was described previously [4]. All
studies were performed on overnight fasted mice except wherelsevier B.V. All rights reserved.
1224 A.M. Andres et al. / FEBS Letters 585 (2011) 1223–1230otherwise stated. All procedures described were approved by the
Institutional Animal Care and Use Committee at San Diego State
University and University of California at Los Angeles.2.2. Isolation of total RNA and quantitative real-time PCR
Total RNA was isolated from frozen tissue samples using the
PerfectPure RNA Isolation Kit (5-Prime). cDNA was generated using
iScript cDNA Synthesis Kit (BioRad). Quantitative real-time PCR
was performed using the SensiMix Plus SYBR Green Kit (Quantace)
on the iCycler system (BioRad). Primers used for GLUT1 mRNA
expression were 50-ggtgtgcagcagcctgtgta-30 (forward) and 50-aac
aaacagcgacaccacagt-30 (reverse). GLUT1 expression levels were
normalized to that of cyclophilin. Primer sequences for cyclophilin
were 50-tggagagcaccaagacagaca-30 (forward) and 50-tgccggagtcga
caatgat-30 (reverse).2.3. Western blotting
Tissues were homogenized in ice-cold buffer containing 50 mM
Tris, pH 8, 150 mM NaCl, 2 mM EGTA, 1 mM EDTA, 1% NP-40, 0.5%
sodium deoxycholate, 0.1% SDS, 20 mM NaF, 1 mM NaVO4, 1 mM
PMSF, 10 lg/ml aprotinin, 10 lg/ml leupeptin and 10 lg/ml pep-
statin. Anti-tubulin antibody was purchased from Sigma. Anti-
pPDH-E1a (Ser-293) was purchased from Calbiochem. Antibodies
for liver kinase B1 (LKB1), GLUT1 and GLUT4 were purchased from
Santa Cruz Biotechnology. All other primary antibodies were pur-
chased from Cell Signaling Technology.2.4. 5-Aminoimidazole-4-carboxyamide ribonucleoside (AICAR)
treatment
Overnight fasted mice were given a subcutaneous injection of
AICAR (0.5 mg/g body weight). Control animals received saline
only. One hour after injection, mice were sacriﬁced and soleus
muscles were processed for Western blot analysis.
2.5. AMPK activity assay
Tissue were homogenized in Buffer A (50 mM Tris–HCl, 1 mM
EDTA, 1 mM EGTA, 1 mM DTT, 50 mM NaF, 5 mM sodium pyro-
phosphate, 10% glycerol, 1% TritonX-100, pH 7.50) in the presence
of protease inhibitor cocktail (Pierce). The homogenate was centri-
fuged for 15 min at 13 500g. AMPK activity was determined using
SAMS peptide as a substrate in the presence of 200 lM AMP as de-
scribed [15]. The standard assay mixture (in 25 ll) contains 40 mM
HEPES (pH 7.0), 80 mMNaCl, 8% glycerol (v/v), 5 mMMgCl, 0.8 mM
EDTA, 0.8 mM dithiothreitol, 0.2 mM ATP, 0.2 mM AMP, 0.2 mM
SAMS peptide and 2 lCi [32P]ATP (cat #35001X, ICN). After
20 min at 30 C, the reaction was terminated by spotting 15 ll of
reaction mixture onto Whatman P81 paper, which was then
washed 5 times in 1% phosphoric acid and once in acetone. The
papers were air-dried and radioactivity was quantitated in 4 ml
scintillation ﬂuid. Activities of each sample were corrected from
no-enzyme controls and normalized to the amount of protein.
2.6. Quantiﬁcation of tissue nucleotides
Assay of nucleotides levels were performed by the NIH Mouse
Metabolic Phenotyping Center at the Yale University School of
Medicine. Tissues were snap-frozen in liquid nitrogen. Frozen tis-
sues (50–100 mg) were extracted with 0.9 N ice-cold perchloric
acid. The concentrations of ATP, ADP, and AMP in the supernatant
were determined by LC/MS.2.7. Tissue glycogen content
Frozen tissues (20–50 mg) were dissolved in 1 N KOH for
20 min at 65 C and treated with activated amyloglucosidase (Sig-
ma) in an acidic buffer overnight at room temperature. Samples
were then neutralized with 1 N NaOH and assayed using a glucose
kit (Wako). Tissue glycogen content is expressed as the amount
free glycosyl units (lmol)/g tissue.2.8. Subcellular fractionation
For LKB1 measurements, cytosolic and nuclear fractions were
prepared as described [16]. For GLUT4 analysis, tissues from over-
night fasted mice were subfractioned as described [17] with minor
modiﬁcations. The ﬁnal pellet was resuspended in buffer contain-
ing 30% sucrose and subject to centrifugation (216 000g) for 1 h
at 4 C to separate the intracellular membranes from the plasma
membranes. GLUT4 protein levels were determined in the mem-
brane fractions by Western blotting.
2.9. Measurement of plasma insulin
Plasma insulin levels of fasted and non-fasted animals were
determined by the Mouse Insulin Lincoplex kit from Millipore.
2.10. Measurement of 2-deoxyglucose uptake
Deoxyglucose uptake in soleus from overnight fasted mice was
determined as described [18]. Soleus muscle from overnight fasted
mice was pre-incubated in oxygenated Krebs-Henseleit Buffer
(KHB) without insulin for 30 min. Muscles were then incubated
for 20 min. in KHB containing 1 mM 2-deoxy-D-[l,2-3H]glucose
(2.25 lCi/ml), 0.3 lCi/ml [U-14C]mannitol, 2 mM sodium pyruvate
and 0.1% BSA. Tissue was blotted dry and digested in Tissue Solu-
bilizer (ICN). Radioactivity was determined by scintillation count-
ing in the presence of 10 ml Cytoscint (Fisher). The amount of
each isotope present in the samples was determined and this infor-
mation was used to calculate the extracellular space and the intra-
cellular concentration of 2-deoxyglucose. Rates of uptake were
normalized to wet muscle mass in each vial.
2.11. Statistical methods
All data are reported as the mean ± standard deviation. Group
mean values were compared by Student’s two-tailed t-test. Results
with P-values <0.05 were considered statistically signiﬁcant.
3. Results
3.1. Activation of AMPK is reduced in oxidative muscle tissues of
fasting TKO mice
We previously demonstrated that cardiac and skeletal muscle-
speciﬁc Txnip KO mice recapitulated the metabolic phenotype of
whole body Txnip KO mice [4]. Since AMPK is the major energy
sensor orchestrating adaptive metabolic changes to fasting, we
investigated if Txnip ablation would affect AMPK signaling in the
heart and skeletal muscle. While total AMPKa protein level in
TKOmice was the same as wild-type (WT) mice, activation of AMP-
Ka through Thr-172 phosphorylation was markedly diminished in
soleus and hearts of fasted TKO mice (Fig. 1A). In contrast, there
was no difference in AMPK activation in soleus and hearts of
non-fasted TKO mice, as compared to the WT controls (Fig. 1B).
Interestingly, activation of AMPK was also not diminished in gas-
trocnemius from both fasted and non-fasted TKO mice (Fig. 1A
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Fig. 1. Effects of Txnip ablation on AMPK activation and ACC phosphorylation. Tissue homogenates from soleus muscle and hearts were prepared from overnight fasted (A)
and non-fasted (B) WT and TKO mice. Equal amounts of protein were resolved by SDS–PAGE. Levels of total AMPK and phospho-AMPKa (pThr-172) were quantiﬁed by
Western blotting. Results are presented as mean ± S.D. from three mice in each group. (C) Phosphorylation levels of the AMPK downstream target ACC (pSer-79) and total ACC
were determined by Western blotting. Results are presented as mean ± S.D. from three mice in each group. (D) AMPK enzyme activity was determined in homogenates from
the heart, soleus and gastrocnemius muscles of fasted WT and TKO mice. Results are presented as mean ± S.D. from three mice in each group. ⁄P < 0.05 and ⁄⁄P < 0.01 versus
control mice.
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Fig. 2. Effects of Txnip ablation on Ser-485/491 phosphorylation of AMPKa.
Samples were prepared as in Fig. 1. Levels of pSer-485/491 in AMPKa in fasted
soleus muscle and hearts were quantiﬁed. Results are presented as mean ± S.D.
from three mice in each group.
A.M. Andres et al. / FEBS Letters 585 (2011) 1223–1230 1225and B). These ﬁndings suggest that Txnip ablation exerts different
effects on oxidative muscles (soleus and cardiac muscle) than gly-
colytic muscles (gastrocnemius). Consistent with reduced AMPK
activation, phosphorylation of acetyl-CoA carboxylase (ACC) at
Ser-79, a downstream AMPK phosphorylation target, was also
diminished in the fasting heart and soleus but not in gastrocne-
mius (Fig. 1C). The reduction in AMPK activation in fasting soleus
and hearts was further conﬁrmed by the decrease in AMPK activity
measured in vitro (Fig. 1D).
3.2. Activation of AMPK by LKB1 and AMP are normal in TKO mice
TKO mice exhibit increased insulin sensitivity [4,19,20]. Phos-
phorylation of AMPK at Ser-485/491 (AMPKa) by the serine/threo-
nine protein kinase B (Akt) is known to inhibit Thr-172
phosphorylation [21]. We examined if the decrease in AMPK acti-
vation could be due to cross-talk inhibition exerted by the insu-
lin/Akt pathway through Ser-485/491 phosphorylation of AMPKa.
No difference in Ser-485/491 phosphorylation levels between
TKO mice and WT control mice was observed (Fig. 2). These data
suggest that hypo-phosphorylation of AMPK at Thr-172 is unlikely
due to the inhibitory action by Akt.
Since LKB1 is the major upstream kinase that phosphorylates
AMPK in response to energydeprivation [22],we examinedwhetherablation of Txnip may have affected the function of LKB1. TKO mice
have similar expression levels of LKB1 as that of WT mice (Fig. 3A),
indicating that Txnip ablation did not alter LKB1 protein expression.
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Fig. 3. Effects of Txnip ablation on LKB1 expression and function. (A) Tissue homogenate from soleus muscle of fasted mice was subfractionated into nuclear and cytosolic
fractions. Ratios of cytosolic LKB1/total LKB1 and nuclear LKB1/total LKB1 were determined. (B) Levels of phospho-MARK1 (phosphorylation loop). Results are presented as
mean ± S.D. (n = 3).
1226 A.M. Andres et al. / FEBS Letters 585 (2011) 1223–1230Nucleocytoplasmic transport and subsequent association of LKB1
with STE20-related adaptor protein (STRAD) and the scaffolding
protein calciumbinding protein 39 (CAB39) in the cytoplasm are re-
quired for full activation of LKB1 andAMPK [23]. Fig. 3A showed that
cytosolic and nuclear distribution of LKB1 level was not altered in
TKO mice. To conﬁrm that LKB1 enzyme activity is not deﬁcient in
TKO mice, we examined the phosphorylation status of MAP/micro-
tubule afﬁnity-regulating kinase 1 (MARK1), another established
LKB1 phosphorylation target. Fig. 3B showed that levels of MARK1
phosphorylation in TKOmice were the same as that of WT controls.
Taken together, these ﬁndings showed that diminished activation of
AMPK in fasting TKO mice is not due to LKB1 deﬁciency. We next
examined if sensing of AMP by AMPK is defective in TKO mice. WT
and TKO mice were treated with AICAR, an AMP analog which is
metabolized to AICARmonophosphate (ZMP)mimicking the stimu-
latory effects of AMP on AMPK [24]. As expected, WT mice treated
with AICAR exhibited a robust increase in Thr-172 phosphorylation
of AMPK when compared to the saline-injected controls (Fig. 4).
Interestingly, TKOmicewere equally responsive to AICAR treatment0
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Fig. 4. Induction of AMPK phosphorylation by AICAR. Overnight fasted WT and TKO
mice (n = 3 per group) were injected (s.c.) with saline or AICAR (0.5 mg/g). One hour
after the treatment, soleus muscle was harvested. Levels of total AMPK and
phospho-AMPKa (Thr-172) were determined by Western blot analysis. A repre-
sentative blot is shown using duplicate samples from each group. Results are
presented as mean ± S.D. ⁄P < 0.05 and NS denotes no signiﬁcant difference versus
WT.(Fig. 4), suggesting that the mechanism by which AMP activates
AMPK is intact in TKO mice.
3.3. Txnip ablation alters cellular AMP:ATP ratio
Results from the AICAR stimulation experiment strongly sug-
gest that intracellular AMP levels may explain the difference in
AMPK activation. Levels of cellular adenosine nucleotides in tissues
from fasted WT and TKO mice were quantiﬁed by LC/MS (Table 1).
In both soleus and hearts, AMP levels in TKO mice were signiﬁ-
cantly reduced compared to WT mice (70.7% and 32.0%, P = 0.002
and 0.006, respectively). Consistent with the ﬁnding that AMPK
phosphorylation was not affected in gastrocnemius, AMP level in
gastrocnemius from fasted TKO mice was not different from that
of WT controls. Fasting ATP level in soleus and gastrocnemius of
TKO mice were both elevated (14.4%, P = 0.037 and 21.8%,
P = 0.0001, respectively), whereas it was reduced in the heart
(9.7%, P = 0.001). AMP:ATP ratio was lower in all three tissues of
TKO mice: soleus (74.5%, P = 0.002), hearts (24.6%, P = 0.034) and
gastrocnemius (20.8%, P = 0.005). Taken together, these data
showed that diminished AMPK activation in fasting TKO soleus
and hearts is not due to deﬁciencies in upstream kinase function
or the capability of AMP to stimulate AMPK, but rather a conse-
quence of decreased cellular AMP levels.Table 1
Quantitative analysis of cellular adenosine nucleotides in fasted mice by LC/MS.
n AMP
(lmol/
g tissue)
ADP
(lmol/
g tissue)
ATP
(lmol/
g tissue)
AMP:ATP
Soleus (fasting)
WT 9 0.318 ± 0.154 0.632 ± 0.090 9.297 ± 1.010 0.034 ± 0.017
TKO 8 0.093 ± 0.021 0.587 ± 0.050 10.635 ± 1.325 0.009 ± 0.002
P 0.002 0.221 0.037 0.002
Heart (fasting)
WT 10 6.529 ± 1.732 0.654 ± 0.097 7.066 ± 0.392 0.927 ± 0.253
TKO 10 4.440 ± 1.108 0.631 ± 0.054 6.379 ± 0.338 0.699 ± 0.183
P 0.006 0.526 <0.001 0.034
Gastrocnemius (fasting)
WT 10 0.206 ± 0.022 0.471 ± 0.044 7.158 ± 0.757 0.029 ± 0.004
TKO 10 0.201 ± 0.039 0.564 ± 0.041 8.719 ± 0.334 0.023 ± 0.004
P 0.707 <0.001 <0.001 0.005
Cellular adenosine nucleotides in overnight fasted WT and TKO mice. Levels of AMP,
ADP and ATP in tissue extracts were determined by LC/MS. Normalized results are
presented as mean ± S.D. P values (WT versus TKO) are presented.
A.M. Andres et al. / FEBS Letters 585 (2011) 1223–1230 12273.4. Increased glucose utilization in muscle tissues of TKO mice is not
associated with glucose transporter expression
One of the key functions of AMPK is to increase glucose uptake
and utilization in response to energy deprivation. Paradoxically, we
found that both glucose uptake and glycolysis were elevated in
fasting TKO mice [4] despite having blunted AMPK activation
(Fig. 1). Plasma levels of insulin in fasting TKO mice are the same
as that of WT mice, whereas insulin levels of non-fasting TKO mice
are lower than that of WT mice (Fig. 5A). Soleus isolated from fast-
ing TKO mice showed increased 2-deoxyglucose uptake in the ab-
sence of insulin (Fig. 5B). This ﬁnding is consistent with those of
Patwari et al. who showed that overexpression of Txnip in cultured
3T3-L1 adipocytes reduced 2-deoxyglucose uptake in the absence
of insulin [13].
We examined if Txnip ablation alters the expression of glucose
transporters GLUT4 and GLUT1. Heart tissues from WT and TKO
mice were subfractionated. Purity and enrichment of plasma
membrane was assessed by the presence of the cell surface marker
b1-integrin (Fig. 6A, top panel). Induction of GLUT4 expression in
plasma membrane samples from AICAR-stimulated WT mice
served as positive controls (Fig. 6A, top panel). No difference was
observed in the abundance of GLUT4 protein on the plasma
membrane between TKO and WT mice (Fig. 6A, bottom panel).
Unexpectedly, GLUT1 protein levels in the heart, soleus and gas-
trocnemius were lower in fasted TKO mice (Fig. 6B); however, no
difference was observed in non-fasted animals (Fig. 6C). Parallel
to the fasting GLUT1 protein difference, GLUT1 mRNA expression
was diminished in fasted TKO mice, suggesting that the reduction
in GLUT1 protein levels is due to transcriptional down-regulation
(Fig. 6D). Since GLUT1 mRNA levels were reduced in gastrocnemius
despite the absence of impairment in AMPK activation, these ﬁnd-
ings indicate the down-regulation of GLUT1 expression by Txnip
ablation acts through a mechanism independent to AMPK
signaling.0
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versus control mice.3.5. Txnip ablation induces inhibition of the mitochondrial pyruvate
dehydrogenase complex, and is associated with increased muscle
glycogen content
High energy state (low AMP:ATP ratio) activates pyruvate dehy-
drogenase kinases (PDKs) [25] which in turn phosphorylates and
inhibits pyruvate dehydrogenase (PDH) [26]. Phosphorylation lev-
els of the PDH-E1a subunit was markedly increased in soleus mus-
cle from fasting TKO mice (Fig. 7A), whereas no difference was
observed in non-fasted mice (P = 0.07, Fig. 7B). This ﬁnding is con-
sistent with our previous data showing that glucose oxidation was
diminished, whereas lactate production and glycolysis were in-
creased in fasted TKO soleus muscles [4].
Glycogen content in the heart and soleus of fasted TKO mice
were dramatically increased (5.6-fold and 5.3-fold, respectively,
Fig. 8A). In non-fasted animals, a trend towards increased glycogen
content in the hearts and soleus of TKO mice versus WT controls
was observed, but did not reach statistical signiﬁcance (P = 0.21
and 0.06, respectively, Fig. 8B). In contrast, glycogen content in
the gastrocnemius of fasted and non-fasted TKO mice were not in-
creased comparing to WT controls (Fig. 8A and B).4. Discussion
Negative feedback mechanisms provide fail-safe measures to
regain homeostasis in biological systems. In the case of counteract-
ing energy deprivation (as in fasting and impaired mitochondrial
oxidation), AMPK senses the decline in cellular energy status and
coordinately modiﬁes metabolic pathways to increase ATP produc-
tion [14]. Activation of mitochondrial fatty acid oxidation by AMPK
signaling in skeletal muscle provides a means to spare glucose for
the brain, which relies on glucose as the major source of energy
during acute fasting [27]. We previously showed that mitochon-
drial oxidation of glucose, fatty acids and ketone bodies were re-
duced in fasted TKO mice [4]. In this study, we further
characterized the metabolic consequences of Txnip ablation and
show for the ﬁrst time that AMPK activation is blunted in the heart
and soleus muscle, but not gastrocnemius muscle, of fasted TKO
mice (Fig. 1A). The reduction in AMPK activation is associated with
a decrease in cellular levels of AMP. This change is speciﬁc to tis-
sues enriched in oxidative ﬁbers (heart and soleus muscle) but
not in those high in glycolytic ﬁbers (gastrocnemius) (Table 1).
The fact that gastrocnemius muscle has a high capacity of glycoly-
sis may explain why it is less susceptible to the effect of impaired
mitochondrial oxidation and increased glucose uptake caused by
Txnip deﬁciency. In contrary, cardiac and soleus muscles contain
more oxidative ﬁbers and thus are more reliant on mitochondrial
oxidation. As a result, the surplus glucose inﬂux is channeled into
glycogen storage. This is supported by our ﬁnding that glycogen
accumulates in heart and soleus of fasting TKO mice but not in gas-
trocnemius (Fig. 8).
Despite having impaired mitochondrial fuel oxidation, we made
a surprising ﬁnding that tissues of fasted TKO mice were in a par-
adoxically higher energetic state (Table 1). As glucose oxidation is
impaired in TKO mice, the paradoxical ﬁnding of an elevated en-
ergy state in fasted TKO mice could be attributed, at least in part,
to the increase in glycolysis as previously reported [4]. Reduced
AMP:ATP ratio favors the phosphorylation and inhibition of PDH
through the activation of PDKs. Forced expression of PDK1 in hyp-
oxic HIF-1a null cells has been shown to increase ATP levels and
shunt glucose metabolites from the mitochondria to glycolysis
[28].
It is presently unclear how Txnip ablation leads to increased
glucose uptake. Fasting insulin levels of TKO mice were not differ-
ent from WT mice (Fig. 5A). Although fasted TKO mice have been
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Fig. 6. Effects of Txnip ablation on GLUT1 and GLUT4 expression. (A) Top panel, heart homogenate from overnight fasted WT mice was subfractionated to obtain enriched
plasma membranes, intermembrane vesicles and cytosolic fractions for Western blot analysis. Thirty micrograms of protein from each fraction was resolved by SDS–PAGE.
Bottom panel, GLUT4 expression in plasma membrane of hearts from overnight fasted WT and TKO mice. (B and C) Levels of GLUT1 protein in fasted (B) and non-fasted (C)
mice. Results are presented as mean ± S.D. (n = 4). (D) Relative expression of GLUT1 mRNA in the heart, soleus and gastrocnemius muscles of fasted WT and TKO mice. Results
are presented as mean ± S.D. (n = 5). ⁄P < 0.05 and ⁄⁄P < 0.01 versus control mice.
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observe any increase in GLUT4 translocation to the plasmamembrane in TKO hearts (Fig. 6A). This may be attributed to the re-
duced AMPK signaling in TKO hearts which leads to decreased
phosphorylation of Akt substrate of 160 kDa (AS160) and GLUT4
translocation [29]. Uptake of 2-deoxyglucose in the absence of
insulin by isolated soleus from fasting TKO mice was increased
comparing to WT controls (Fig. 5B). In accordance with ﬁndings
from overexpression studies of Txnip in cultured adipocytes [13],
our data suggest that increased uptake of glucose in muscle is
likely mediated by an insulin-independent mechanism. Previously,
we showed that streptozotocin treatment normalized plasma
triglyceride levels in Txnip null HcB-19 mice and led to hypergly-
cemia in both control and HcB-19 mice. The seemingly contradict-
ing ﬁndings on the role of insulin in these two studies can be
reconciled by the fact that insulin affects glucose secretion by the
liver but not glucose uptake in the muscle. Absence of insulin in
streptozotocin-treated mice suppresses hepatic lipoprotein and
leads to uncontrolled hepatic glucose output.
Despite have increased glucose uptake, GLUT1 protein expres-
sion was unexpectedly lower in fasting TKO mice, whereas no dif-
ference was observed in non-fasting animals (Fig. 6B and C). The
down-regulation of GLUT1 transcription appears to be indepen-
dent to AMPK as GLUT1 expression in gastrocnemius from fasting
TKO mice was also reduced (Fig. 6D). The role of Txnip in
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Fig. 8. Effects of Txnip ablation on glycogen content. Glycogen content in the heart,
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control mice.
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indicate that modulation of glucose uptake by Txnip does not in-
volve increased recruitment of the two most abundant glucose
transporters, namely GLUT1 and GLUT4, in the muscle. Mutagene-
sis studies demonstrated that modulation of glucose uptake by
Txnip in cultured cells was independent of its ability to bind thio-
redoxin-1 and that regulation of glucose uptake was intrinsic to
the arrestin-like domain in Txnip [13]. This raised the possibility
that Txnip might act as a scaffold protein facilitating the interac-
tions between other regulatory proteins of glucose metabolism.
For example, it was discovered that Txnip interacts with NLRP3
and plays an essential role in regulating inﬂammasome activities
[30]. Interestingly, NLRP3 knockout mice also exhibited increased
glucose tolerance and insulin sensitivity similar to the phenotype
of TKO mice, suggesting that the inﬂammasome pathway could
be linked to the regulation of glucose homeostasis by Txnip [30].
Although the present study cannot exclude the possibility of alter-
ations in other hexose transporters and their kinetic properties, a
plausible explanation for the increase in glucose uptake without
apparent increase in GLUT1 and GLUT4 expression could be, in
part, due to increased rate of glycolysis [4] and the diversion of glu-
cose metabolites to glycogen storage (Fig. 8).
McBride et al. demonstrated that glycogen inhibited AMPK
activity in a highly puriﬁed cell-free system [31]. AMPK associates
with glycogen synthase and glycogen phosphorylase in skeletal
muscle [32]. The b subunits of AMPK contain a central conserved
glycogen-binding domain which mediates the association between
AMPK and glycogen. These ﬁndings suggest that AMPK may mon-
itor the level of cellular energy reserve in the form of glycogen, in
addition to its well-established role as immediate energy sensor of
the AMP:ATP ratio. Physiological studies also showed that muscle
AMPK activity is modulated by glycogen content [33,34]; however,
the underlying mechanisms are poorly understood. Glycogen de-
pleted muscle exhibits greater AMPK activation by AICAR treat-
ment or by exercise, whereas glycogen loading represses AMPK
activation [33,34]. In fasted TKO mice, cellular glycogen contentwas found to be dramatically increased in soleus and hearts
(Fig. 8). This is in line with data from hyperinsulinemic–euglyce-
mic clamp studies showing that whole body rates of glycolytic
and glycogen synthesis were signiﬁcantly elevated in TKO mice
[35]. The increased glycogen content, in addition to the observed
decrease in AMP levels, may further attenuate AMPK activation.
Similar to the metabolic phenotype of TKO mice, increased plasma
lactate levels and muscle glycogen content are associated with hu-
man mitochondrial insufﬁciency disorders [36–38].
Txnip is intimately linked to cellular carbohydrate and mito-
chondrial metabolism through the glucose sensing transcriptional
complex MondoA:Mlx [39–41]. Increased glycolytic ﬂux down-
regulates Txnip gene expression [41]. Induction of Txnip by lactic
acidosis acts as a feedback mechanism to reduce glucose uptake
and lactate production, whereas this protective measure is blunted
in Txnip deﬁcient cells [40]. In addition to promoting mitochon-
drial oxidation to generate ATP from fatty acid and ketone bodies
oxidation, AMPK reduces the deleterious effects of lactic acidosis.
Activation of AMPK in skeletal muscle induces the expression of
monocarboxylate transporter-4 [42], which is the predominant
transporter for lactate efﬂux. The inability of TKO mice to up-
regulate Txnip and activate AMPK pathway could reduce the toler-
ance to lactic acidosis and contribute to the increased mortality
during long term fasting. Glucose sparing by skeletal muscles dur-
ing fasting is a crucial evolutionary adaption to survival since the
brain can only utilize glucose as energy source during early stage
of starvation. Our studies highlight the indispensible role of Txnip
in maintaining glucose homeostasis and adapting to starvation
through AMPK signaling.Acknowledgements
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